B. Bengtsson

发表

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

L. Lönn, L. Sjöström, J. Svensson, 1998, The Journal of clinical endocrinology and metabolism.

Beneficial effects of long‐term GH replacement therapy on quality of life in adults with GH deficiency

B. Bengtsson, G. Johannsson, B. Bengtsson, 1998, Clinical endocrinology.

A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults.

J. Svensson, I. Bosaeus, G. Johannsson, 2007, The Journal of clinical endocrinology and metabolism.

A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.

M. Alpsten, J. Svensson, I. Bosaeus, 2001, The Journal of clinical endocrinology and metabolism.

A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.

M. Taskinen, J. Svensson, O. Wiklund, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).

M. Taskinen, J. Svensson, J. Jansson, 1999, The Journal of clinical endocrinology and metabolism.

Diurnal variation in serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH‐deficient adults

B. Bengtsson, P. Lundberg, G. Johannsson, 1997, Clinical endocrinology.

Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors

L. Wilhelmsen, B. Bengtsson, B. Bengtsson, 1999, Clinical endocrinology.

Growth hormone (GH) therapy in GH-deficient adults influences the response to a dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low density lipoprotein cholesterol levels.

O. Wiklund, I. Bosaeus, G. Johannsson, 1999, The Journal of clinical endocrinology and metabolism.

Normal concentrations of serum insulin-like growth factor-1 in late polio.

G. Grimby, P. Lundberg, B. Bengtsson, 1995, Archives of physical medicine and rehabilitation.

U-shaped association between mortality and blood pressure in a thirteen-year prospective study.

J. Lanke, B. Bengtsson, L. Lindholm, 1986, Family practice.

Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.

O. Wiklund, B. Bengtsson, T. Rosén, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Elevated fibrinogen levels decrease following treatment of acromegaly

L. Wilhelmsen, B. Bengtsson, B. Bengtsson, 1997, Clinical endocrinology.

Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.

L. Wilhelmsen, G. Lappas, B. Bengtsson, 1997, European journal of endocrinology.

Influence of gender and gonadal steroids on responsiveness to growth hormone replacement therapy in adults with growth hormone deficiency.

G. Johannsson, B. Bengtsson, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Familial resemblance in casual blood pressure--a maternal effect?

B. Bengtsson, B. Scherstén, T. Thulin, 1979, Clinical science.

Epidemiology and mortality in 220 patients with polymyalgia rheumatica.

B. Bengtsson, B. Bengtsson, R. Andersson, 1995, British journal of rheumatology.

Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity.

P. Björntorp, O. Wiklund, B. Bengtsson, 1996, Metabolism: clinical and experimental.

Rethink about growth-hormone therapy for critically ill patients

B. Bengtsson, 1999, The Lancet.

Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.

J. Svensson, I. Bosaeus, G. Johannsson, 2007, European journal of endocrinology.

Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project).

L. Wilhelmsen, P. Lundberg, T. Rosén, 1995, European journal of clinical nutrition.

Serum intact parathyroid hormone in a random population sample of men and women: Relationship to anthropometry, life-style factors, blood pressure, and vitamin D

L. Wilhelmsen, P. Lundberg, T. Rosén, 1995, Calcified Tissue International.

Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP‐6

J. Svensson, J. Jansson, L. Frohman, 1998, Clinical endocrinology.

Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).

M. Taskinen, J. Svensson, J. Jansson, 1999, The Journal of clinical endocrinology and metabolism.

Both high and low blood pressures risk indicators of death in middle-aged males. Isotonic regression of blood pressure on age applied to data from a 13-year prospective study.

J. Lanke, G. Ejlertsson, B. Bengtsson, 2009, Acta medica Scandinavica.

GH is needed for the maturation of muscle mass and strength in adolescents.

G. Grimby, G. Johannsson, B. Bengtsson, 2001, The Journal of clinical endocrinology and metabolism.

Assessment of casual blood pressure variations

B. Bengtsson, B. Scherstén, T. Thulin, 1978, Postgraduate medical journal.

Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.

J. Svensson, K. Sunnerhagen, B. Bengtsson, 2001, The Journal of clinical endocrinology and metabolism.

Can growth hormone therapy cause diabetes?

B. Bengtsson, B. Bengtsson, U. Feldt-Rasmussen, 2000, The Lancet.

Can growth hormone therapy cause diabetes? KIMS Strategic Committee.

B. Bengtsson, U. Feldt-Rasmussen, C. Wüster, 2000, The Lancet.

Back pain: a study of twins.

B. Bengtsson, J. Thorson, 1991, Acta geneticae medicae et gemellologiae.

Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes.

L. Wilhelmsen, O. Wiklund, B. Bengtsson, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Premature mortality due to cardiovascular disease in hypopituitarism

B. Bengtsson, T. Rosén, B. Bengtsson, 1990, The Lancet.

Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.

B. Bengtsson, B. Bengtsson, B. Jonsson, 2000, The Journal of clinical endocrinology and metabolism.

Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.

J. Svensson, T. Rosén, G. Johannsson, 2004, The Journal of clinical endocrinology and metabolism.

The effect of metoprolol treatment on insulin sensitivity and diurnal plasma hormone levels in hypertensive subjects

M. Elam, P. Lönnroth, S. Gudbjörnsdottir, 1997, European journal of clinical investigation.